The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Singer Michael | Director | Gift(G) | 7K | — | $0 |
| Jan 6, 2026 | Davis Blaine | Chief Financial Officer | Sell(S) | 11K | $6.82 | $72K |
| Jan 6, 2026 | Miljkovic Milos | Chief Medical Officer | Sell(S) | 4K | $6.82 | $24K |
| Jan 6, 2026 | Brunn Carsten | President and CEO, Director | Sell(S) | 24K | $6.82 | $162K |
| Jan 2, 2026 | Kalayoglu Murat | Director, 10% Owner | Grant(A) | 3K | — | $0 |
| Jan 2, 2026 | Kalayoglu Murat | Director, 10% Owner | Grant(A) | 8K | — | $0 |
| Jan 2, 2026 | Springer Timothy A | Director, 10% Owner | Grant(A) | 3K | — | $0 |
| Jan 2, 2026 | Springer Timothy A | Director, 10% Owner | Grant(A) | 8K | — | $0 |
| Jan 2, 2026 | Singer Michael | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2026 | Singer Michael | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2026 | English Emily | Chief Operations Officer | Grant(A) | 24K | — | $0 |
| Jan 2, 2026 | English Emily | Chief Operations Officer | Grant(A) | 71K | — | $0 |
| Jan 2, 2026 | Barabe Timothy C | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2026 | Barabe Timothy C | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2026 | Davis Blaine | Chief Financial Officer | Grant(A) | 37K | — | $0 |
| Jan 2, 2026 | Davis Blaine | Chief Financial Officer | Grant(A) | 109K | — | $0 |
| Jan 2, 2026 | Seymour June Ann | Chief Accounting Officer | Grant(A) | 7K | — | $0 |
| Jan 2, 2026 | Seymour June Ann | Chief Accounting Officer | Grant(A) | 19K | — | $0 |
| Jan 2, 2026 | Zenner Patrick J | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2026 | Zenner Patrick J | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2026 | Miljkovic Milos | Chief Medical Officer | Grant(A) | 27K | — | $0 |
| Jan 2, 2026 | Miljkovic Milos | Chief Medical Officer | Grant(A) | 77K | — | $0 |
| Jan 2, 2026 | Malik Kemal | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2026 | Malik Kemal | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2026 | Brunn Carsten | President and CEO, Director | Grant(A) | 143K | — | $0 |
| Jan 2, 2026 | Brunn Carsten | President and CEO, Director | Grant(A) | 416K | — | $0 |
| Jan 2, 2026 | DeSilva Nishan M | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2026 | DeSilva Nishan M | Director | Grant(A) | 8K | — | $0 |
| Dec 30, 2025 | English Emily | Chief Operations Officer | Option exercise(M) | 8K | $3.30 | $25K |
| Dec 30, 2025 | English Emily | Chief Operations Officer | Option exercise(M) | 8K | — | — |
| Dec 16, 2025 | Bot Adrian Ion | Director | Grant(A) | 6K | — | $0 |
| Dec 16, 2025 | Bot Adrian Ion | Director | Grant(A) | 17K | — | $0 |
| Dec 4, 2025 | Barabe Timothy C | Director | Buy(P) | 30K | $6.86 | $206K |
| Nov 28, 2025 | English Emily | Chief Operations Officer | Option exercise(M) | 8K | $3.30 | $25K |
| Nov 28, 2025 | English Emily | Chief Operations Officer | Option exercise(M) | 8K | — | — |
| Nov 18, 2025 | Singer Michael | Director | Gift(G) | 20K | — | $0 |
| Oct 27, 2025 | Seymour June Ann | Chief Accounting Officer | Grant(A) | 50K | — | $0 |
| May 12, 2025 | English Emily | Chief Operations Officer | Option exercise(M) | 8K | $3.30 | $25K |
| May 12, 2025 | English Emily | Chief Operations Officer | Option exercise(M) | 8K | — | — |
| Apr 15, 2025 | English Emily | Chief Operations Officer | Option exercise(M) | 8K | $3.30 | $25K |
| Apr 15, 2025 | English Emily | Chief Operations Officer | Option exercise(M) | 8K | — | — |
| Apr 11, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 6K | $10.77 | $69K |
| Apr 11, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 36K | $10.77 | $391K |
| Apr 10, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 45K | $10.43 | $471K |
| Apr 10, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 8K | $10.43 | $83K |
| Apr 10, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 609 | $10.92 | $7K |
| Apr 10, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 3K | $10.92 | $38K |
| Apr 9, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 31 | $9.95 | $308 |
| Apr 9, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 178 | $9.95 | $2K |
| Apr 9, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 42K | $9.43 | $392K |
| Apr 9, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 7K | $9.43 | $69K |
| Mar 20, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 55K | $15.59 | $856K |
| Mar 19, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 20K | $14.97 | $303K |
| Mar 18, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 15K | $14.42 | $213K |
| Jan 14, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 4K | $18.00 | $72K |
| Jan 13, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 8K | $16.86 | $134K |
| Jan 13, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 9K | $17.78 | $160K |
| Jan 10, 2025 | Jewell Christopher M | Chief Scientific Officer | Option exercise(M) | 9K | $3.23 | $29K |
| Jan 10, 2025 | Jewell Christopher M | Chief Scientific Officer | Option exercise(M) | 9K | — | — |
| Jan 6, 2025 | Davis Blaine | Chief Financial Officer | Sell(S) | 4K | $16.83 | $68K |
| Jan 6, 2025 | Brunn Carsten | President and CEO, Director | Sell(S) | 9K | $16.83 | $147K |
| Jan 6, 2025 | English Emily | Chief Operations Officer | Sell(S) | 906 | $16.83 | $15K |
| Jan 6, 2025 | Jewell Christopher M | Chief Scientific Officer | Sell(S) | 1K | $16.83 | $22K |
| Jan 6, 2025 | Miljkovic Milos | Chief Medical Officer | Sell(S) | 948 | $16.83 | $16K |
| Jan 6, 2025 | Kurtoglu Metin | Chief Technology Officer | Sell(S) | 2K | $16.83 | $41K |
| Jan 3, 2025 | Davis Blaine | Chief Financial Officer | Sell(S) | 4K | $16.72 | $66K |
| Jan 3, 2025 | Brunn Carsten | President and CEO, Director | Sell(S) | 9K | $16.72 | $143K |
| Jan 3, 2025 | English Emily | Chief Operations Officer | Sell(S) | 891 | $16.72 | $15K |
| Jan 3, 2025 | Jewell Christopher M | Chief Scientific Officer | Sell(S) | 1K | $16.72 | $21K |
| Jan 3, 2025 | Miljkovic Milos | Chief Medical Officer | Sell(S) | 932 | $16.72 | $16K |
| Jan 3, 2025 | Kurtoglu Metin | Chief Technology Officer | Sell(S) | 2K | $16.72 | $40K |
| Jan 2, 2025 | DeSilva Nishan M | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2025 | DeSilva Nishan M | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2025 | Cox Carrie Smith | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2025 | Cox Carrie Smith | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2025 | Singer Michael | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2025 | Singer Michael | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2025 | Kurtoglu Metin | Chief Technology Officer | Grant(A) | 16K | — | $0 |
| Jan 2, 2025 | Kurtoglu Metin | Chief Technology Officer | Grant(A) | 47K | — | $0 |
| Jan 2, 2025 | Malik Kemal | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2025 | Malik Kemal | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2025 | Springer Timothy A | Director, 10% Owner | Grant(A) | 3K | — | $0 |
| Jan 2, 2025 | Springer Timothy A | Director, 10% Owner | Grant(A) | 8K | — | $0 |
| Jan 2, 2025 | Barabe Timothy C | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2025 | Barabe Timothy C | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2025 | Kalayoglu Murat | Director, 10% Owner | Grant(A) | 3K | — | $0 |
| Jan 2, 2025 | Kalayoglu Murat | Director, 10% Owner | Grant(A) | 8K | — | $0 |
| Jan 2, 2025 | Miljkovic Milos | Chief Medical Officer | Grant(A) | 19K | — | $0 |
| Jan 2, 2025 | Miljkovic Milos | Chief Medical Officer | Grant(A) | 56K | — | $0 |
| Jan 2, 2025 | Zenner Patrick J | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2025 | Zenner Patrick J | Director | Grant(A) | 8K | — | $0 |
| Jan 2, 2025 | Davis Blaine | Chief Financial Officer | Grant(A) | 22K | — | $0 |
| Jan 2, 2025 | Davis Blaine | Chief Financial Officer | Grant(A) | 65K | — | $0 |
| Jan 2, 2025 | English Emily | Chief Operations Officer | Grant(A) | 16K | — | $0 |
| Jan 2, 2025 | English Emily | Chief Operations Officer | Grant(A) | 47K | — | $0 |
| Jan 2, 2025 | Jewell Christopher M | Chief Scientific Officer | Grant(A) | 16K | — | $0 |
| Jan 2, 2025 | Jewell Christopher M | Chief Scientific Officer | Grant(A) | 47K | — | $0 |
| Jan 2, 2025 | Brunn Carsten | President and CEO, Director | Grant(A) | 58K | — | $0 |
| Jan 2, 2025 | Brunn Carsten | President and CEO, Director | Grant(A) | 169K | — | $0 |
| Dec 26, 2024 | English Emily | SVP, Head of Manufacturing | Option exercise(M) | 8K | $3.30 | $25K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).